Acceptability of a Human Papillomavirus (HPV) Trial Vaccine Among Mothers of Adolescents in Cuernavaca, Mexico
- 31 May 2001
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 32 (3), 243-247
- https://doi.org/10.1016/s0188-4409(01)00277-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Phase IIa Safety and Immunogenicity of a Therapeutic Vaccine, TA‐GW, in Persons with Genital WartsThe Journal of Infectious Diseases, 1999
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997
- HPV Vaccine Treatment Trials Proliferate, DiversifyJNCI Journal of the National Cancer Institute, 1997
- A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancerThe Lancet, 1996
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.Proceedings of the National Academy of Sciences, 1995
- The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spainInternational Journal of Cancer, 1992
- Hepatitis B: global importance and need for controlVaccine, 1990